Protocol for the Digital, Individualized, and Collaborative Treatment of Type 2 Diabetes in General Practice Based on Decision Aid (DICTA)—A Randomized Controlled Trial
Nutrients · 2025
DOI: 10.3390/nu17152494 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Sofie Frigaard Kristoffersen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Odense, Odense University Hospital, 5000 Odense, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Decision Support Techniques, General Practice. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation "Steno Collaborative Grants", Novo Nordisk Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Despite significant advancements in diabetes care, many individuals with type 2 diabetes (T2D) do not receive optimal care and treatment. Digital interventions promoting behavioral changes have shown promising long-term results in supporting healthier lifestyles but are not implemented in most healthcare offerings, maybe due to lack of general practice support and collaboration. This study evaluates the efficacy of the Digital, Individualized, and Collaborative Treatment of T2D in General Practice Based on Decision Aid (DICTA), a randomized controlled trial integrating a patient-centered smartphone application for lifestyle support in conjunction with a clinical decision support (CDS) tool to assist general practitioners (GPs) in optimizing antidiabetic treatment.
Methods
The present randomized controlled trial aims to recruit 400 individuals with T2D from approximately 70 GP clinics (GPCs) in Denmark. The GPCs will be cluster-randomized in a 2:3 ratio to intervention or control groups. The intervention group will receive one year of individualized eHealth lifestyle coaching via a smartphone application, guided by patient-reported outcomes (PROs). Alongside this, the GPCs will have access to the CDS tool to optimize pharmacological decision-making through electronic health records. The control group will receive usual care for one year, followed by the same intervention in the second year.
Results
The primary outcome is the one-year change in estimated ten-year cardiovascular risk, assessed by SCORE2-Diabetes calculated from age, smoking status, systolic blood pressure, total and high-density lipoprotein cholesterol, age at diabetes diagnosis, HbA1c, and eGFR.
Conclusions
If effective, DICTA could offer a scalable, digital-first approach for improving T2D management in primary care by combining patient-centered lifestyle coaching with real-time pharmacological clinical decision support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Steno Diabetes Center Odense, Odense University Hospital, 5000 Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark.
- Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5230 Odense, Denmark.
- Research Unit of General Practice, 8000 Aarhus, Denmark.
- DRIVEN, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, 5230 Odense, Denmark.
- Research Unit of User Perspectives and Community-Based Interventions, Department of Public Health, University of Southern Denmark, 5230 Odense, Denmark.
ORCID-Profile: Sofie Frigaard Kristoffersen, Jeanette Reffstrup Christensen, Sally Wullf Jørgensen, Dorte E Jarbøl, Jens Søndergaard, Carl J Brandt
Förderung
- Novo Nordisk Foundation "Steno Collaborative Grants"
- Novo Nordisk Foundation
Zitieren
APA
Kristoffersen, S. F., Christensen, J. R., Jeremiassen, L. M. R., Kylkjær, L. B., Christensen, N. R., Jørgensen, S. W., Kristensen, J. K., Wehberg, S., Raymond, I. E., Jarbøl, D. E., Nielsen, J. B., Søndergaard, J., Olsen, M. H., Nielsen, J. S., & Brandt, C. J. (2025). Protocol for the Digital, Individualized, and Collaborative Treatment of Type 2 Diabetes in General Practice Based on Decision Aid (DICTA)—A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu17152494
Vancouver
Kristoffersen SF, Christensen JR, Jeremiassen LMR, Kylkjær LB, Christensen NR, Jørgensen SW, et al. Protocol for the Digital, Individualized, and Collaborative Treatment of Type 2 Diabetes in General Practice Based on Decision Aid (DICTA)—A Randomized Controlled Trial. Nutrients. 2025. doi:10.3390/nu17152494
BibTeX
@article{Kristoffersen2025,
author = {Kristoffersen, Sofie Frigaard and Christensen, Jeanette Reffstrup and Jeremiassen, Louise Munk Ramo and Kylkjær, Lea Bolette and Christensen, Nanna Reffstrup and Jørgensen, Sally Wullf and Kristensen, Jette Kolding and Wehberg, Sonja and Raymond, Ilan Esra and Jarbøl, Dorte E and Nielsen, Jesper Bo and Søndergaard, Jens and Olsen, Michael Hecht and Nielsen, Jens Steen and Brandt, Carl J},
title = {Protocol for the Digital, Individualized, and Collaborative Treatment of Type 2 Diabetes in General Practice Based on Decision Aid (DICTA)—A Randomized Controlled Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17152494}
}
EUVIMED